Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) channel, an ATP binding cassette (ABC) transporter. CFTR gating is linked to ATP binding and dimerization of its two nucleotide binding domains (NBDs). Channel activation also requires phosphorylation of the R domain by poorly understood mechanisms. Unlike conventional ligand-gated channels, CFTR is an ATPase for which ligand (ATP) release typically involves nucleotide hydrolysis. The extent to which CFTR gating conforms to classic allosteric schemes of ligand activation is unclear. Here, we describe point mutations in the CFTR cytosolic loops that markedly increase ATP-independent (constitutive) channel activity. This finding is consistent with an allosteric gating mechanism in which ligand shifts the equilibrium between inactive and active states but is not essential for channel opening. Constitutive mutations mapped to the putative symmetry axis of CFTR based on the crystal structures of related ABC transporters, a common theme for activating mutations in ligand-gated channels. Furthermore, the ATP sensitivity of channel activation was strongly enhanced by these constitutive mutations, as predicted for an allosteric mechanism (reciprocity between protein activation and ligand occupancy). Introducing constitutive mutations into CFTR channels that cannot open in response to ATP (i.e., the G551D CF mutant and an NBD2-deletion mutant) substantially rescued their activities. Importantly, constitutive mutants that opened without ATP or NBD2 still required R domain phosphorylation for optimal activity. Our results confirm that (i) CFTR gating exhibits features of protein allostery that are shared with conventional ligandgated channels and (ii) the R domain modulates CFTR activity independent of ATP-induced NBD dimerization.ATP binding cassette transporter | cystic fibrosis | ligand | constitutive | mutant C ystic fibrosis transmembrane conductance regulator (CFTR) is a member of the ATP binding cassette (ABC) transporter superfamily, although it is the only known ion channel in this transporter family (1). Like other ABC transporters, CFTR uses ATP binding to its two nucleotide binding domains (NBDs) to drive conformational rearrangements of its transmembrane domains (2, 3). CFTR channel opening is linked to ATP binding to each of two sites at the interface of an NBD1-NBD2 dimer (2, 3). Subsequent hydrolysis, typically at site 2 (primarily composed of sequences from NBD2), promotes channel closure by clearing ligand from this site (4, 5). The coupling between ATP binding and pore opening is presumably mediated by the cytosolic loops that physically link the NBDs to the transmembrane domains (6, 7).Because CFTR is an enzyme that normally hydrolyzes its ligand as part of the channel gating cycle, the extent to which its properties are similar to those of more conventional ligand-gated channels is an interesting issue. Ligand-gated channels such as acetylcholine receptors obey the principles of protein alloster...